Protective role of soluble CD52 in obesity-associated steatotic liver disease and glucose dysregulation in mice.
Saved in:
| Title: | Protective role of soluble CD52 in obesity-associated steatotic liver disease and glucose dysregulation in mice. |
|---|---|
| Authors: | Miyazawa Y; Department of Clinical Pharmacology, University of Toyama, 2630 Sugitani, Toyama, Japan., Wada T; Department of Clinical Pharmacology, University of Toyama, 2630 Sugitani, Toyama, Japan. Electronic address: twada@pha.u-toyama.ac.jp., Iwasa Y; Department of Clinical Pharmacology, University of Toyama, 2630 Sugitani, Toyama, Japan., Fuse K; Department of Clinical Pharmacology, University of Toyama, 2630 Sugitani, Toyama, Japan., Shioneri H; Department of Clinical Pharmacology, University of Toyama, 2630 Sugitani, Toyama, Japan., Onogi Y; Research Center for Pre-Disease Science, University of Toyama, 2630 Sugitani, Toyama, Japan., Sameshima A; Department of Obstetrics and Gynecology, University of Toyama, 2630 Sugitani, Toyama, Japan., Yoshida T; Department of Molecular Neuroscience, University of Toyama, 2630 Sugitani, Toyama, Japan., Takasaki I; Department of Pharmacology, Graduate School of Science and Engineering, University of Toyama, 3190 Gofuku, Toyama, Japan., Mori H; Department of Molecular Neuroscience, University of Toyama, 2630 Sugitani, Toyama, Japan., Koizumi K; Research Center for Pre-Disease Science, University of Toyama, 2630 Sugitani, Toyama, Japan; Division of Presymptomatic Disease, Institute of Natural Medicine, University of Toyama, 2630 Sugitani, Toyama, Japan., Tsuneki H; Department of Clinical Pharmacology, University of Toyama, 2630 Sugitani, Toyama, Japan; Department of Integrative Pharmacology, University of Toyama, 2630 Sugitani, Toyama, Japan., Saito S; Research Center for Pre-Disease Science, University of Toyama, 2630 Sugitani, Toyama, Japan., Sasaoka T; Department of Clinical Pharmacology, University of Toyama, 2630 Sugitani, Toyama, Japan. Electronic address: tsasaoka@pha.u-toyama.ac.jp. |
| Source: | Molecular metabolism [Mol Metab] 2026 Jan; Vol. 103, pp. 102279. Date of Electronic Publication: 2025 Nov 04. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier GmbH Country of Publication: Germany NLM ID: 101605730 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2212-8778 (Electronic) Linking ISSN: 22128778 NLM ISO Abbreviation: Mol Metab Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41197951 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Protective role of soluble CD52 in obesity-associated steatotic liver disease and glucose dysregulation in mice. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Miyazawa+Y%22">Miyazawa Y</searchLink>; Department of Clinical Pharmacology, University of Toyama, 2630 Sugitani, Toyama, Japan.<br /><searchLink fieldCode="AU" term="%22Wada+T%22">Wada T</searchLink>; Department of Clinical Pharmacology, University of Toyama, 2630 Sugitani, Toyama, Japan. Electronic address: twada@pha.u-toyama.ac.jp.<br /><searchLink fieldCode="AU" term="%22Iwasa+Y%22">Iwasa Y</searchLink>; Department of Clinical Pharmacology, University of Toyama, 2630 Sugitani, Toyama, Japan.<br /><searchLink fieldCode="AU" term="%22Fuse+K%22">Fuse K</searchLink>; Department of Clinical Pharmacology, University of Toyama, 2630 Sugitani, Toyama, Japan.<br /><searchLink fieldCode="AU" term="%22Shioneri+H%22">Shioneri H</searchLink>; Department of Clinical Pharmacology, University of Toyama, 2630 Sugitani, Toyama, Japan.<br /><searchLink fieldCode="AU" term="%22Onogi+Y%22">Onogi Y</searchLink>; Research Center for Pre-Disease Science, University of Toyama, 2630 Sugitani, Toyama, Japan.<br /><searchLink fieldCode="AU" term="%22Sameshima+A%22">Sameshima A</searchLink>; Department of Obstetrics and Gynecology, University of Toyama, 2630 Sugitani, Toyama, Japan.<br /><searchLink fieldCode="AU" term="%22Yoshida+T%22">Yoshida T</searchLink>; Department of Molecular Neuroscience, University of Toyama, 2630 Sugitani, Toyama, Japan.<br /><searchLink fieldCode="AU" term="%22Takasaki+I%22">Takasaki I</searchLink>; Department of Pharmacology, Graduate School of Science and Engineering, University of Toyama, 3190 Gofuku, Toyama, Japan.<br /><searchLink fieldCode="AU" term="%22Mori+H%22">Mori H</searchLink>; Department of Molecular Neuroscience, University of Toyama, 2630 Sugitani, Toyama, Japan.<br /><searchLink fieldCode="AU" term="%22Koizumi+K%22">Koizumi K</searchLink>; Research Center for Pre-Disease Science, University of Toyama, 2630 Sugitani, Toyama, Japan; Division of Presymptomatic Disease, Institute of Natural Medicine, University of Toyama, 2630 Sugitani, Toyama, Japan.<br /><searchLink fieldCode="AU" term="%22Tsuneki+H%22">Tsuneki H</searchLink>; Department of Clinical Pharmacology, University of Toyama, 2630 Sugitani, Toyama, Japan; Department of Integrative Pharmacology, University of Toyama, 2630 Sugitani, Toyama, Japan.<br /><searchLink fieldCode="AU" term="%22Saito+S%22">Saito S</searchLink>; Research Center for Pre-Disease Science, University of Toyama, 2630 Sugitani, Toyama, Japan.<br /><searchLink fieldCode="AU" term="%22Sasaoka+T%22">Sasaoka T</searchLink>; Department of Clinical Pharmacology, University of Toyama, 2630 Sugitani, Toyama, Japan. Electronic address: tsasaoka@pha.u-toyama.ac.jp. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101605730%22">Molecular metabolism</searchLink> [Mol Metab] 2026 Jan; Vol. 103, pp. 102279. <i>Date of Electronic Publication: </i>2025 Nov 04. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+GmbH%22">Elsevier GmbH </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>101605730 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2212-8778 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2222128778%22">22128778 </searchLink><i>NLM ISO Abbreviation: </i>Mol Metab <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41197951 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.molmet.2025.102279 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 102279 Titles: – TitleFull: Protective role of soluble CD52 in obesity-associated steatotic liver disease and glucose dysregulation in mice. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Miyazawa Y – PersonEntity: Name: NameFull: Wada T – PersonEntity: Name: NameFull: Iwasa Y – PersonEntity: Name: NameFull: Fuse K – PersonEntity: Name: NameFull: Shioneri H – PersonEntity: Name: NameFull: Onogi Y – PersonEntity: Name: NameFull: Sameshima A – PersonEntity: Name: NameFull: Yoshida T – PersonEntity: Name: NameFull: Takasaki I – PersonEntity: Name: NameFull: Mori H – PersonEntity: Name: NameFull: Koizumi K – PersonEntity: Name: NameFull: Tsuneki H – PersonEntity: Name: NameFull: Saito S – PersonEntity: Name: NameFull: Sasaoka T IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 01 Text: 2026 Jan Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 2212-8778 Numbering: – Type: volume Value: 103 Titles: – TitleFull: Molecular metabolism Type: main |
| ResultId | 1 |